The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 001, hydroquinone 4, tretinoin 005) compared with hydroquinone 4 cream in Asian patients with moderate to severe melasma
Open accessAbstract
BACKGROUND: Melasma is an acquired, chronic hypermelanosis for which therapy remains a challenge. OBJECTIVES: To compare the efficacy and safety of a triple combination [TC: fluocinolone acetonide 0.01%, hydroquinone (HQ) 4%, tretinoin 0.05%] vs. HQ 4% after 8 weeks of treatment of moderate to severe facial melasma in Asian patients. METHODS: This was a multicentre, randomized, controlled, investigator-blinded, parallel comparison study. East and South-East Asian patients aged 18 years or older, with a clinical diagnosis of moderate to severe melasma, were enrolled in this study. Patients were enrolled at baseline and treated daily for 8 weeks with TC cream (one application at bedtime) or HQ cream (twice daily). There were four study visits: at baseline and weeks 2, 4 and 8. The primary efficacy variable was the melasma global severity score (GSS). Other outcome measures included Melasma Area and Severity Index, global improvement and patient satisfaction. Safety was assessed through the reporting of adverse events. RESULTS: TC had superior efficacy to HQ for the primary variable: 77/120 patients (64.2%) on TC had GSS 'none' or 'mild' at week 8 vs. 48/122 patients (39.4%) on HQ (P < 0.001). The secondary efficacy variables confirmed these results. Patient satisfaction was in favour of TC (90/127, 70.8%, vs. 64/129, 49.6%; P = 0.005). More patients had related adverse events on TC (63/129, 48.8%) than on HQ (18/131, 13.7%) but most were mild and none was severe. CONCLUSIONS: Efficacy in Asians and patient satisfaction were superior with the fixed TC than with HQ 4%.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The level of evidence for this study is graded as Level 2b according to the Oxford Centre for Evidence‐Based Medicine.”
From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [69]
In the citing paper
“The study found that the triple combination treatment was significantly more effective in reducing pigmentation and improving melasma compared to hydroquinone alone.”
From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [69]
In the citing paper
“However, the study had some limitations including a small sample size and a relatively short follow‐up period of 12 weeks. Additionally, the study did not report any adverse events or long‐term outcomes of the triple combination treatment.”
From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [69]
Citations
Cites
Fitzpatrick’s Dermatology in General Medicine
(1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70018-x · Cited by 3,235
A New Formula for Depigmenting Human Skin
Kligman, A. M. (1975) · Archives of Dermatology · doi:10.1001/archderm.1975.01630130042004 · Cited by 430
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial
Kimbrough-Green, C. K. (1994) · Archives of Dermatology · doi:10.1001/archderm.130.6.727 · Cited by 418
Melasma: histopathological characteristics in 56 Korean patients
Kang, W.-H., Yoon, K., Lee, E., Kim, J., Lee, K. B., Yim, H. W., Sohn, S., & Im, S. (2002) · British Journal of Dermatology · doi:10.1046/j.0007-0963.2001.04556.x · Cited by 400
Self-citationEthnic skin types: are there differences in skin structure and function? 1
Rawlings, A. V. (2006) · International Journal of Cosmetic Science · doi:10.1111/j.1467-2494.2006.00302.x · Cited by 389
DISORDERS OF HYPERPIGMENTATION
Pandya, A. G., & Guevara, I. L. (2000) · Dermatologic Clinics · doi:10.1016/s0733-8635(05)70150-9 · Cited by 248
Rendon, M. I., Berneburg, M., Arellano, I., & Picardo, M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.12.039 · Cited by 215
Light Microscopic, Immunohistochemical, and Ultrastructural Alterations in Patients with Melasma
Grimes, P. E., Yamada, N., & Bhawan, J. (2005) · American Journal of Dermatopathology · doi:10.1097/01.dad.0000154419.18653.2e · Cited by 209
Acquired, bilateral nevus of Ota-like macules
Hori, Y., Kawashima, M., Oohara, K., & Kukita, A. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80313-8 · Cited by 207
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Taylor, S. C., Torok, H., Jones, T., Lowe, N. J., Rich, P. A., Tschen, E. H., Menter, A., Baumann, L., Wieder, J. J., Jarratt, M., et al. (2003) · PubMed · Cited by 170
Research works printed but not linked: 2
- Mosher, 1999, Fitzpatricks Dermatology in General Medicine, 945
- Kumarasinghe, 2005, The Asian Skin A Reference Color Atlas of Dermatology, 48
Cited by
Sorted by citations
Items 101–132 of 132
Weedon, D. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-3485-5.00011-5 · Cited by 3
Profile of depigmenting cosmetics and dermatological products on the market
Rotava, P. A., Favero, J. D. S., Garcia, K. R., & Angeli, V. W. (2020) · Revista de ciencias farmaceuticas · doi:10.4322/2179-443x.0643 · Cited by 3
Hu, H., Zhou, P., Yao, H., Zhu, C., Shen, B., Feng, B., Yu, X., & Liu, L. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70205 · Cited by 2
Abad‐Casintahan, M. F., & Lim, H. G. (2017) · Springer eBooks · doi:10.1007/978-81-322-3664-1_12 · Cited by 2
Passeron, T. (2012) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(12)70120-5 · Cited by 2
Pigmentation Disorders - Etiology and Recent Advances in Treatments
Aghaei, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100979 · Cited by 2
Choudhary, N., De, A., Sil, A., & Chatterjee, G. (2020) · Serbian Journal of Dermatology and Venerology · doi:10.2478/sjdv-2020-0001 · Cited by 2
“There are various modalities of treatment in the form of topical creams and ointments (steroid and hydroquinone containing triple combination cream (9, 10), arbutin (11), kojic acid (12), hydroquinone), oral agents (tranexamic acid) (13, 14) and cosmetic procedures such as chemical peeling (glycolic acid (15), trichlo…”
BackgroundElethawi, A. M. D., & Al-Gurairi, F. T. (2024) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2024/v36i25362 · Cited by 1
Khan, M. M. U., & Ahamed, A. R. S. (2013) · Faridpur Medical College Journal · doi:10.3329/fmcj.v8i1.16893 · Cited by 1
Galappatthy, P., & Rathnayake, D. (2018) · Updates in clinical dermatology · doi:10.1007/978-3-319-70419-7_18 · Cited by 1
Callender, V. D., & Davis, E. C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0859-2.00022-x · Cited by 1
Illuminating the shadows: an insight into periorbital hyperpigmentation
Awal, G., Kaur, N., & Shubham (2024) · Pigment International · doi:10.4103/pigmentinternational_8_24 · Cited by 1
Cosmiatric Approach for Melasma
Handel, A. C., Miot, L. D. B., & Miot, H. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-20250-1_25-1 · Cited by 1
Momin, A. M., Mistry, A. A., & Vaishnani, J. (2020) · International Journal of Research in Dermatology · doi:10.18203/issn.2455-4529.intjresdermatol20202658 · Cited by 1
“01% was superior to HQ 4% monotherapy in improving melisma.(27)”
MethodKwon, K. H. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.33.005372 · Cited by 1
“In a 12-week follow-up study which compared topical TCC treatment to QS-ruby laser treatment for solar lentigines, both patients and physicians found the QS-ruby laser to be superior in terms of how quickly a therapeutic effect was achieved, treatment duration, and degree of improvement [9].”
Salim, A., Rajaratnam, R., & Domanne, E. S. (2014) · doi:10.1002/9781118357606.ch55 · Cited by 1
Traitement topique des hyperpigmentations
Rendon, M. I., & Horwitz, S. (2012) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(12)70119-9
Hajheydari, Z., Bahari, M., Golpour, M., Charati, J. Y., باعث, م., & Mohammadpour, R. A. (2015) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences
Treatment options for melasma: an update
Ghersetich, I., Bassi, A., Betti, S., Campolmi, P., & Lotti, T. (2011) · Prime · doi:10.1080/21598908.2011.601578
Melasma and Common Pigmentary Dermatoses in Asian Individuals an Overview of their
Park, K. C. (2014)
Self-citationShankar, K., Godse, K. V., Aurangabadkar, S., Tarang, B., Lahiri, K. D., Square, M., Mysore, V., Ganjoo, A., Kohli, M., Secrets, S., et al. (2014)
Bleach peeling for melasma: an effective approach to treatment
Zenker, S. (2018) · Journal of Aesthetic Nursing · doi:10.12968/joan.2018.7.3.136
“Traditional topical drugs, such as HQ, tretinoin and corticosteroids, can be found in well-known prescription formulations, such as triple combination creams or Kligman’s formula (Torok et al, 2005; Chan et al, 2008).”
BackgroundPark, K., & Kang, H. Y. (2018) · Updates in clinical dermatology · doi:10.1007/978-3-319-70419-7_12
Self-citationCurrent awareness: Pharmacoepidemiology and drug safety
(2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1644
Handog, V., & Macarayo, M. J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735863229.793562000
Caccavari (2022) · Drugs in Context · doi:10.7573/dic.2022-11-2
Aim to prevent acne-induced post-inflammatory hyperpigmentation as treatment remains a challenge
Lamb, Y. N. (2022) · Drugs & Therapy Perspectives · doi:10.1007/s40267-022-00932-8
Laser pigmentari: utilizzo su lesioni pigmentate e tatuaggi
Jourdan, M. (2024) · EMC - Cosmetologia Medica e Medicina degli Inestetismi Cutanei · doi:10.1016/s1776-0313(24)48812-6
Yellumahanthi, D. K. (2024) · Springer eBooks · doi:10.1007/978-3-031-68406-7_9
Assessment and Treatment of Photoaging-related Mottled Pigmentation
Na, S. Y., & Park, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-26027-5.00050-4
Self-citationAlghamdi, S. M. H., Alahmadi, M. A., Alghanmi, R. M., Bajamaan, D. K., & Algarni, A. S. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04369-7
“In the included studies, alternative interventions such as tranexamic acid and cysteamine were evaluated against Kligman’s formula, with some studies reporting comparable or superior outcomes with these newer agents [ 27 , 28, 34, 39 ].”
Sawant, M., Mayabhate, M. M., & Sharma, A. (2026) · International Journal of Research in Dermatology · doi:10.18203/issn.2455-4529.intjresdermatol20261931
Metadata
- Authors
- Chan, R., Park, K. C., Lee, M. H., Lee, E.-S., Chang, S. E., Leow, Y. H., Tay, Y.-K., Legarda-Montinola, F., Tsai, R.-Y., Tsai, T.-H., Shek, S., Kerrouche, N., Thomas, G., & Verallo-Rowell, V.
- Affiliations
- National Skin Centre (SG)
- Seoul National University Bundang Hospital (KR)
- Kyung Hee University (KR)
- Ajou University Hospital (KR)
- Asan Medical Center (KR)
- Changi General Hospital (SG)
- Makati Medical Center (PH)
- Wan Fang Hospital (TW)
- Queen Mary Hospital (CN)
- Galderma (France) (FR)
- Corresponding author
- Chan, R.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06
- Volume
- 159
- Issue
- 3
- Pages
- ???-???
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W1980482640
- Cited by
- 132
- References
- 28
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 13 · 2023: 4 · 2022: 15 · 2021: 3 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 14 · 2016: 6 · 2015: 7 · 2014: 12 · 2013: 3 · 2012: 8
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- Locations
- British Journal of Dermatology (publishedVersion)
- PubMed (publishedVersion)
- AJOU Open Repository (Ajou University) (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- Galderma
- Topics
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- melasma, triple combination therapy, fluocinolone acetonide, hydroquinone, all-trans retinoic acid, Asian patients, facial hyperpigmentation, Melasma Area and Severity Index, patient satisfaction, adverse events, topical treatment efficacy
- MeSH terms
- Administration, Cutaneous, Adult, Analysis of Variance, Double-Blind Method, Drug Combinations, Facial Dermatoses, Female, Fluocinolone Acetonide, Humans, Hydroquinones, Male, Melanosis, Middle Aged, Ointments, Tretinoin, Treatment Outcome, Patient Satisfaction, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
